Mennica Polska S.A. (MNC)
Warsaw Stock Exchange · Poland · prices in PLN · close of 23 Oct 2026
Key indicators
| Last close | PLN 38.50 |
|---|---|
| 52-week range | 31.40 – 59.00 |
| Return, 1 month / 3 months | −0.8% / +6.9% |
| Return, 1 year / 3 years | +17.5% / +163.9% |
| Trend | Below its 200-day average |
| RSI (14) | 44 |
| Volatility (1 year) | 37.0% |
| Worst drawdown (1 year) | -31.1% |
| Average daily value traded | 0.11M PLN |
| Dividend yield | 3.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Mennica Polska is a Polish mint based in Warsaw that produces circulating coins for Poland and strikes collector coins, medals and commemorative pieces, along with investment gold and silver products for collectors and investors. Through its payments business it supplies electronic payment services, including transport ticketing systems and payment terminals used by merchants and public transport operators. The company also provides precious metal trading and related services to individual and institutional customers.
On this site Mennica Polska S.A. appears as a stock on the Warsaw Stock Exchange (Poland), code MNC, with prices in Polish zloty (PLN). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Mennica Polska S.A. (MNC) trades on the Warsaw Stock Exchange in Poland. It last closed at PLN 38.50 on 23 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 275 of 580 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 17.5% and over the last three months it rose 6.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Warsaw Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 36 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -8.7% | ||
| From 52-week high | -28.2% | ||
| Momentum | 57 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 6.9% | ||
| 6-month return | -14.5% | ||
| 12-month return, skipping the last month | 18.4% | ||
| Stability (higher is calmer) | 57 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 37.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.1% | ||
| Liquidity | 68 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.11M PLN | ||
| Zero-volume days | 0.0% | ||
| Income | 55 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.9% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
Returns
| 1 week | −0.8% |
|---|---|
| 1 month | −0.8% |
| 3 months | +6.9% |
| 6 months | −14.5% |
| 1 year | +17.5% |
| 3 years | +163.9% |
| 5 years | +113.4% |
Signals
| 50-day / 200-day average | 39.91 / 42.18 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.16 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 May 2026 | PLN 1.5000 |
| 14 Jul 2025 | PLN 0.5000 |
| 14 May 2024 | PLN 1.2500 |
| 15 Jun 2023 | PLN 0.1000 |
| 3 Jun 2022 | PLN 0.7000 |
| 17 Jun 2021 | PLN 0.3000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Warsaw Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.